If you need more lookups,
subscriptions start at $34 USD/month.
Dave Demarco Location
South Kingstown, RI, US
Dave Demarco Work
Chief Innovation and Growth Officer @ (February 2020 - Present)
Chair of the Board Emeritus, National Board of Directors @ (January 2017 - Present)
Board Member @ (January 2021 - Present)
Partner, Deputy US Health Leader @ (July 2016 - June 2017)
Partner, Northeast Life Sciences Leader @ (July 2012 - June 2016)
Global Coordinating Services Partner, Johnson and Johnson @ (July 2006 - December 2014)
VP Strategy @ (April 2006 - December 2006)
Global Aesthetics Franchise Leader @ (April 2004 - December 2005)
VP Strategy and Transformation @ (June 2000 - March 2004)
Dave Demarco Education
Purdue University
Doctor of Philosophy (Ph.D.) (Chemistry)
1978-1982
Grove City College
Bachelor's degree (Chemistry)
1974-1978
Dave Demarco Skills
Acquisition Integration
Acquisitions
Business Process Improvement
Business Strategy
Business Transformation
Change Management
Consulting
Corporate Development
Cross-functional Team Leadership
Divestitures
Due Diligence
Enterprise Risk Management
Financial Modeling
Leadership
M&A experience
Management
Management Consulting
Mergers
Mergers & Acquisitions
Operational Excellence
Organizational Design
Performance Improvement
Pharmaceutical Industry
Process Improvement
Restructuring
Start-ups
Strategic Planning
Strategy
Dave Demarco Summary
Dave Demarco, based in South Kingstown, RI, US, is currently a Chief Innovation and Growth Officer at Material Health Strategies. Dave Demarco brings experience from previous roles at American Diabetes Association, Cohen Veterans Bioscience and Ernst & Young. Dave Demarco holds a 1978 - 1982 Doctor of Philosophy (Ph.D.) in Chemistry @ Purdue University. With a robust skill set that includes Acquisition Integration, Acquisitions, Business Process Improvement, Business Strategy, Business Transformation and more. Dave Demarco has 6 emails and 7 mobile phone numbers on RocketReach.
Looking for a different Dave Demarco?
Find contact details for 700 million professionals.